News

Atossa Therapeutics to Lead Innovative Discussion at BIO-Europe

Atossa Therapeutics to Lead Innovative Discussion at BIO-Europe

Atossa Therapeutics and Karolinska Institute Unite for a Pioneering Discussion

Atossa Therapeutics, Inc. (NASDAQ: ATOS) has announced an exciting opportunity for engagement at BIO-Europe 2024. The company’s Chairman and CEO, Dr. Steven Quay, will participate in a fireside chat alongside Dr. Per Hall, a distinguished Professor of Epidemiology from the Karolinska Institute. This discussion is poised to highlight an innovative collaboration focused on the prevention of breast cancer through advanced therapeutic strategies.

Exploring the Intersection of AI and Breast Cancer Prevention

The main theme of the fireside chat will delve into the integration of artificial intelligence (AI) with emerging therapies aimed at preventing breast cancer in individuals identified as high-risk. The conversation will explore Dr. Hall’s leadership in the Stockholm Mammography Risk Stratified Trial, or SMART study, a groundbreaking study that aims to recruit roughly 70,000 women. This initiative will assess an individualized, imaging-based screening model intended to pinpoint women at the highest risk for developing breast cancer within the next two years, potentially leading to preventative treatment using (Z)-endoxifen.

Details of the Upcoming Fireside Chat

The fireside chat at BIO-Europe 2024 is set to occur on November 4th at 5:00 PM CET in Room K11, Stockholmsmässan. It promises to offer exciting insights into the future of breast cancer preventative measures and the implications of integrating AI in clinical settings.

Groundbreaking Insights from Industry Leaders

Dr. Steven Quay expressed his enthusiasm for this collaboration, stating, "Joining Dr. Hall to share insights on how AI and (Z)-endoxifen could reshape breast cancer treatment is truly an honor. The SMART study's findings could revolutionize the approach to identifying women who might benefit from preventative measures before breast cancer develops." This assertion reflects the hope and commitment to utilizing cutting-edge methodologies in addressing breast cancer, an area of significant medical need.

About Atossa Therapeutics

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stands at the forefront of oncology innovation, focusing on developing novel treatments to meet crucial medical gaps, particularly concerning breast cancer. The company is dedicated to advancing (Z)-endoxifen as a promising candidate for both the prevention and treatment of breast cancer. With the relentless effort of their involved teams, Atossa aims to make significant advancements in cancer therapy.

Contact Information

For more details regarding Atossa's initiatives or inquiries related to their projects, interested parties can reach out to:

Michael Parks
VP, Investor and Public Relations
Phone: 484-356-7105
Email: michael.parks@atossainc.com

Frequently Asked Questions

What is the BIO-Europe 2024 event?

BIO-Europe 2024 is a premier partnering conference for the biotech industry, focusing on business development and networking opportunities.

What is the SMART study?

The SMART study aims to enroll 70,000 women to evaluate an imaging-based screening model for breast cancer risk assessment.

Who are the key speakers at the fireside chat?

Dr. Steven Quay from Atossa Therapeutics and Dr. Per Hall from the Karolinska Institute will lead the discussion.

How does AI contribute to breast cancer prevention?

AI can enhance risk modeling for breast cancer, helping identify women who would benefit from preventative treatments.

How can I learn more about Atossa Therapeutics?

For more information, visit the company's website or reach out to their public relations team for inquiries.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Finding Your Ideal Home Cleaning Schedule: Insights

Updated Category News Views 49

Tackling the Mess: What's Your Cleaning Game Plan? We each have our tidiness tales, but when it comes down to keeping the household shipshape, the professional cleaning schedule you pick can make all the difference. A fresh-off-the-press breakdown from HelloNation and their expert David Merreot can guide you through the choices, cutting through the clutter of confusion....

Continue Reading
Paolo Moretti: New CEO Steering RINA's Dynamic Course

Updated Category News Views 2

Leadership Shift in the Heart of RINA Today's news is a hefty dose of strategic sea change over at RINA S.p.A., where Paolo Moretti's been handed the reins as the new Group Chief Executive Officer. Now, if you haven't been following, RINA's been riding a serious wave—revenues have more than doubled in a neat five-year streak, claiming over a billion euros. So, what we...

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 3

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading
Investor Yazan Al Homsi Backs Arcanus Aerial for $500K

Updated Category News Views 96

Yazan Al Homsi Backs Canadian Innovation Every once in a while, you see a move in the market that feels bigger than the numbers on the page. That's what this $500,000 from Yazan Al Homsi into Arcanus Aerial Systems does. Al Homsi, a UAE-based investor with a solid pedigree, decided to pump half a million bucks into Arcanus just as it's setting down roots in Canadian soil...

Continue Reading
OwnATC Empowers Trainers to Expand Access to Care

Updated Category News Views 5

The Untapped Potential of Athletic Trainers In a hustle to get people's bodies moving and grooving right, we often overlook a crucial player: the Certified Athletic Trainer (CAT). These folks have been shelved in schools or sports arenas for far too long, especially when their expertise could be lighting up communities across the map. Enter OwnATC, shaking things up. A...

Continue Reading
Leviton Ignites Bridgestone Arena's Modern Makeover

Updated Category News Views 36

A Power Play in Technology: Leviton's Big Move Forget your lazy Sunday strolls, the latest buzz is all about connectivity at sports arenas. Leviton, the century-old stalwart in networking and electrical solutions, has just tied the knot with the Nashville Predators to electrify Bridgestone Arena. This ain't just a handshake deal; it's a calculated step to transform how...

Continue Reading
Gemmy's Orchestra of Lights Op. 2 Unveils New Show

Updated Category News Views 6

Jazzing Up the Holidays with Gemmy's Latest Innovation Just when you thought holiday displays couldn't get more extravagant, along comes Gemmy with its latest wonder—the Orchestra of Lights™ Op. 2. Exclusively hitting Lowe's shelves, this isn't your average set of twinkling bulbs. It's an all-out sensory assault, mixing tunes straight out of yuletide hit lists with...

Continue Reading
Better Home & Finance Faces Class Action: What's Next?

Updated Category News Views 78

Stock Hit and Legal Drama Panic set in when Better Home & Finance Holding Company took a 28.5% nosedive after spilling some less-than-sweet news. Their promise of hitting a billion in monthly loans? Stuck in limbo as borrower trepidation reared its ugly head amidst rising rates. Investors felt the heat, watching shares skydive $12.17, landing them at a bruised $30.52. A...

Continue Reading
Violet PR's Big Wins Hint at Industry Strategies

Updated Category News Views 6

A Shining Night in Morristown Picture Violet PR's team on top of the world, right there in Morristown, getting the accolades every agency dreams of—five awards from PRSA-NJ. It's not just an ego trip, either. This is about setting a high bar in the world of strategic communications, and they're flaunting their ability to drive growth and innovation in the economic...

Continue Reading
Home Insurance Gaps: Risky Assumptions Uncovered

Updated Category News Views 43

Unseen Threats to Homeownership Safety Liability gaps in insurance are like those stubborn stains on the carpet you keep missing—nearly invisible until you're flat on your face. In Alpharetta and Fulton County, homes aren't as secure from financial pitfalls as their charming façades suggest. So, what's the danger that folks are glossing over here? Hidden Dangers of...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Snowflake's Recent Options Activity and Market Trends

Updated Category News Views 154

Uncovering Snowflake's Options Activities Recently, large financial players have shown a bullish outlook on Snowflake. A significant number of notable trades have indicated that investors are taking interest in the possibility of positive price movements for this company. An Overview of Trades Upon reviewing the options history for Snowflake (NYSE: SNOW), we identified a...

Continue Reading
Understanding Mesoblast’s U.S. Origin Designation and Benefits

Updated Category News Views 161

Mesoblast’s U.S. Origin Designation Explained In the realm of innovative healthcare, Mesoblast Limited has made significant strides as a frontrunner in allogeneic cellular medicines targeting inflammatory diseases. With its products manufactured from U.S. donors and within U.S. borders, Mesoblast proudly holds the U.S. origin designation for its allogeneic cell...

Continue Reading
Celebration of Creativity at the National Gingerbread Contest

Updated Category News Views 190

Excitement Surrounds the National Gingerbread House Competition The National Gingerbread House Competition is a beloved event that showcases remarkable baking talent and creativity. The 2025 competition at The Omni Grove Park Inn & Spa has brought immense joy, drawing participants from all corners of the nation. This year, the competition was particularly special as it...

Continue Reading
Nexans Welcomes Julien Hueber as New CEO for Growth

Updated Category News Views 886

Leadership Change at Nexans Nexans is undertaking a significant shift in leadership by appointing Julien Hueber as the new Chief Executive Officer, succeeding Christopher Guérin. This transition aims to energize the company and bolster its position in the market. Immediate Implementation of Changes The decision to bring Hueber aboard was made by the Board of Directors...

Continue Reading
SKHL: Direxion's Bold 2X Dive into Semiconductor ETFs

Updated Category News Views 9

Direxion's New Play in Memory: Betting on SK hynix Ah, the smell of leverage in the morning—nothing shakes the cobwebs quite like it. Direxion just rolled out the paperwork for their new Direxion Daily SK Hynix Bull 2X ETF, ticker SKHL if you're keeping track. It's a fresh card in the stack of high-risk, high-reward funds they've got going. If you need a reminder,...

Continue Reading